PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology-Reference-Cited by-同舟云学术

PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology

Published:2011-07 Issue:1 Volume:43 Page:293-303
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Giorgi M.,Melchiorri G.,Nuccetelli V.,D'Angelo V.,Martorana A.,Sorge R.,Castelli V.,Bernardi G.,Sancesario G.

Funder

MIUR

Publisher

Elsevier BV

Subject

Neurology

Reference55 articles.

1. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;Beavo;Physiol. Rev.,1995

2. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol. Rev.,2006

3. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice;Chalimoniuk;Biochem. Biophys. Res. Commun.,2004

4. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice;Chalimoniuk;Neuroscience,2006

5. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease;Chung;J. Immunol.,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats;Molecules;2024-09-11

2. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

3. Molecular imaging beyond dopamine and serotonin in familial and idiopathic Parkinson’s disease;Neuroimaging in Parkinson�s Disease and Related Disorders;2023

4. Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence;Molecules;2022-12-02

5. Phosphodiesterase 10A (PDE10A): Regulator of Dopamine Agonist-Induced Gene Expression in the Striatum;Cells;2022-07-16